more_reports
GREY:CSE; AGNPF:OTCQB; AGW2:XFRA

Grey Matters Health Inc.

Grey Matters Health Inc. is a Canadian healthcare company primarily focused on the establishment of a new national network of dedicated brain PET scanning clinics in the U.S. under the NovaScan Neuroimaging Clinics TM brand, for the early-stage detection of AD and other forms of dementia, as well as epilepsy, neuro-oncology, and movement disorders including Parkinson's disease.


Grey Matters Health is also the parent company of Algernon NeuroScience, a wholly owned subsidiary, that has been advancing a psychedelic program investigating a proprietary form of DMT for stroke and traumatic brain injury recovery, and has a drug development program for Repirinast, a repurposed drug for CKD. The Company's chronic cough drug Ifenprodil, which works by stopping cough in the brain, was sold for USD $2M cash and a 20% equity position in Seyltx Inc., a private U.S. based drug development company that continues to advance research on the drug.
GREY:CSE AGNPF:OTCQB AGW2:XFRA

Grey Matters Health Inc. is a billboard sponsor of Streetwise Reports and paid a fee for this company profile page. Please refer to the important disclosures below for additional details.

Recent Articles:

New Alzheimer's Drugs Are Changing Brain Scans. This Company Is Preparing for What Comes Next

  ()
Grey Matters Health Inc. (GREY:CSE; AGNPF:OTCQB; AGW2:XFRA) is developing dedicated brain PET imaging clinics as new Alzheimer's treatments introduce follow-up scans and Medicare removes its once-per-lifetime restriction.

Solving a 10,000-Pound Problem: This Company Aims to Reinvent the Brain Scan

  ()
Grey Matters Health Inc. (GREY:CSE; AGNPF:OTCQB; AGW2:XFRA) is preparing to open its first dedicated brain PET imaging clinic as new Alzheimer's treatments drive demand for earlier, specialized imaging.

Chart Buy Signals After Co. Targeting U.S. Alzheimer's Market Reports Final Major Regulatory Milestone

Contributed Technical Analyst Opinion
  ()
Technical Analyst Stewart Thomson reviews Grey Matters Health Inc. (GREY:CSE; AGNPF:OTCQB; AGW0:FRA) following its achievement of a major regulatory milestone.

Grey Matters Health Inc. Targets Alzheimer's PET Imaging Opportunity

  ()
Grey Matters Health Inc. advances first U.S. brain-dedicated PET clinic for Alzheimer's detection amid surging diagnostics demand. Learn the key facts for investors.

First-of-Its-Kind US Brain Imaging Clinic Takes Delivery of Key PET Scanner

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) received its first brain-dedicated PET scanning system for its flagship Florida NovaScan Neuroimaging Clinic, which the company said will be the first U.S. facility dedicated to brain-only PET imaging for Alzheimer's disease and other neurological conditions.

Grey Matters Health Inc. Advances US Alzheimer's Clinics

  ()
Grey Matters Health Inc. closes CA$1.25M financing to launch brain-specific PET clinics targeting the expanding Alzheimer's diagnostics market and early detection demand.

More Articles


Experts Following This Company

Stewart Thomson – Thomson Research

Company News 

9/23/2026 – Grey Matters Announces the Closing of its Equity and Convertible Debenture Private Placement totalling CAD $1.12 Million

9/16/2026 – Grey Matters Announces an Increase to its Equity and Convertible Debenture Private Placement to CAD $1.1 Million

9/10/2026 – Grey Matters Closes First Tranche of $600,000 of its Equity and Convertible Debenture Private Placement

Important Disclosures
Grey Matters Health Inc. is a Billboard advertiser of Streetwise Reports and pays a flat fee. Fees fund both sponsor-specific activities and general report activities. Sponsor-specific activities may include aggregating content and publishing that content on the Streetwise Reports site, creating and maintaining company landing pages, interviewing key management, posting a banner/billboard, and/or issuing press releases. The fees also cover the costs for Streetwise Reports to publish and syndicate investment opinion and comments, and also to curate or create sector-specific content. Billboard advertising monthly fees range from $3,000 to $5,000. This landing page contains a summary of the company that was prepared by that company. Some landing pages contain investing highlights and a catalyst calendar that are prepared by that company. The Expert Comments and Experts Following This Company sections of the landing page are compiled by Streetwise Reports. There may be other information about the company that is not placed on the landing page, and Streetwise Reports does not guarantee the accuracy or thoroughness of the information contained on the landing page. Readers should conduct their own research for all information publicly available concerning the company. This landing page may be considered advertising for the purposes of 18 U.S.C. 1734.

streetwise book logo Streetwise Company Fact Sheet
Grey Matters Health Inc. Content